Liquidia Technologies (LQDA) Defended by Needham & Company Despite Tyvaso DPI Approval, Cites "Significant Potential of Yutrepia"
Tweet Send to a Friend
Needham & Company analyst Serge Belanger reiterated a Buy rating and $12.00 price target on Liquidia Technologies (NASDAQ: LQDA), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
